<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04529759</url>
  </required_header>
  <id_info>
    <org_study_id>AL39</org_study_id>
    <nct_id>NCT04529759</nct_id>
  </id_info>
  <brief_title>Healthy Term Infants Fed Milk-Based Infant Formula</brief_title>
  <official_title>Tolerance of Healthy Term Infants Fed Milk-Based Infant Formula With Oligosaccharides</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, double-blind, parallel, feeding study with the purpose to&#xD;
      evaluate the tolerance of healthy term infants fed partially hydrolyzed whey protein infant&#xD;
      formulas.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 12, 2020</start_date>
  <completion_date type="Actual">June 18, 2021</completion_date>
  <primary_completion_date type="Actual">June 18, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean rank stool consistency (MRSC)</measure>
    <time_frame>Study Day 1 to 28 Days of Age</time_frame>
    <description>Parent Completed Diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>14 to 119 Days of Age</time_frame>
    <description>Interval weight gain per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal tolerance</measure>
    <time_frame>14 to 119 Days of Age</time_frame>
    <description>Parent Completed Diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length</measure>
    <time_frame>14 to 119 Days of Age</time_frame>
    <description>Interval length gain per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head Circumference</measure>
    <time_frame>14 to 119 Days of Age</time_frame>
    <description>Interval head circumference gain per day</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Infant Stool Characteristics</measure>
    <time_frame>Study Day 1 to 119 Days of Age</time_frame>
    <description>Parent Completed Diary</description>
  </other_outcome>
  <other_outcome>
    <measure>Study Product Intake</measure>
    <time_frame>Study Day 1 to 119 Days of Age</time_frame>
    <description>Parent Completed Diary</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant and Household Characteristics</measure>
    <time_frame>Study Day 1 to 119 Days of Age</time_frame>
    <description>Parent reported lifestyle and illness questions</description>
  </other_outcome>
  <other_outcome>
    <measure>Health Resource Utilization</measure>
    <time_frame>Study Day 1 to 119 Days of Age</time_frame>
    <description>Number of Visits</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant Feeding and Stool Patterns Questionnaire</measure>
    <time_frame>Exit or 119 Days of Age</time_frame>
    <description>Parent completed questionnaire; 16, 5-point Likert scale questions, scaled in the negative direction</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant Behavior Questionnaire</measure>
    <time_frame>Exit or 119 Days of Age</time_frame>
    <description>Parent completed questionnaire; 22 questions with 5-point Likert scale questions; scaled in the negative direction</description>
  </other_outcome>
  <other_outcome>
    <measure>Formula Satisfaction Questionnaire</measure>
    <time_frame>Exit or 119 Days of Age</time_frame>
    <description>Parent completed questionnaire; 13 questions of up to 5 categories scaled in the negative direction</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Study Day 1 to 119 Days of Age</time_frame>
    <description>Standard adverse event reporting</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Tolerance</condition>
  <arm_group>
    <arm_group_label>Control Infant Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Feed ad libitum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Feed ad libitum</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Infant Formula</intervention_name>
    <description>Powdered partially hydrolyzed whey (WPH) based formula with an oligosaccharide</description>
    <arm_group_label>Control Infant Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Infant Formula</intervention_name>
    <description>Powdered partially hydrolyzed whey (WPH) based formula with oligosaccharides blend</description>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Good health as determined from participant's medical history&#xD;
&#xD;
          -  Singleton from a full-term birth with a gestational age of 37-42 weeks&#xD;
&#xD;
          -  Birth weight was &gt; 2490 g (~5 lbs. 8 oz.)&#xD;
&#xD;
          -  Parent(s) confirm their intention to feed their infant the study product as the sole&#xD;
             source of nutrition for the duration of the study&#xD;
&#xD;
          -  Parent(s) confirm their intention not to administer vitamin or mineral supplements,&#xD;
             (except for vitamin D supplements if instructed by their healthcare professional),&#xD;
             solid foods or juices to their infant from enrollment through the duration of the&#xD;
             study&#xD;
&#xD;
          -  Participant's parent(s) has voluntarily signed and dated an Informed Consent Form&#xD;
             (ICF), approved by an Institutional Review Board/Independent Ethics Committee&#xD;
             (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or&#xD;
             other applicable privacy regulation) authorization prior to any participation in the&#xD;
             study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  An adverse maternal, fetal or participant medical history that is thought by the&#xD;
             investigator to have potential for effects on tolerance, growth, and/or development&#xD;
&#xD;
          -  Participant is taking and plans to continue taking medications (including over the&#xD;
             counter (OTC), such as MyliconÂ® for gas), prebiotics, probiotics, home remedies (such&#xD;
             as juice for constipation), herbal preparations or rehydration fluids that might&#xD;
             affect gastrointestinal (GI) tolerance&#xD;
&#xD;
          -  Participant is enrolled in another study that has not been approved as a concomitant&#xD;
             study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Lasekan, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Visions Clinical Research</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PAS Research, LLC</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Springs Medical Research</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>43203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Clinical Research</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Pediatric Research Center, LLC</name>
      <address>
        <city>Westlake</city>
        <state>Ohio</state>
        <zip>44145</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midsouth Center for Clinical Research</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

